Xu, H., Sheng, L., Chen, W., Yuan, F., Yang, M., Li, H., . . . Chen, L. (2016). Safety, tolerability, pharmacokinetics, and pharmacodynamics of novel glucokinase activator HMS5552: Results from a first-in-human single ascending dose study. Drug Des Devel Ther.
Chicago Stili AlıntıXu, Hongrong, et al. "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Novel Glucokinase Activator HMS5552: Results From a First-in-human Single Ascending Dose Study." Drug Des Devel Ther 2016.
MLA AlıntıXu, Hongrong, et al. "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Novel Glucokinase Activator HMS5552: Results From a First-in-human Single Ascending Dose Study." Drug Des Devel Ther 2016.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..